May 23, 2016 Sophia Vida
Biotech & Pharma

22nd Century Group, Inc. (NYSE: XXII) Launches New Line of Research Cigarettes

Shares of 22nd Century Group Inc. (NYSE: XXII) saw a bump in share price on Monday following news released on Friday. The company revealed that it has launched a new line of Research Cigarettes with varying levels of nicotine. Shares soared nearly 15% compared to Friday’s closing price. The company’s new proprietary Research Cigarettes are … Continue reading “22nd Century Group, Inc. (NYSE: XXII) Launches New Line of Research Cigarettes”